Krystallenia Alexandraki
Krystallenia Alexandraki
National and Kapodistrian University of Athens, Medical School, Division of Endocrinology
Verified email at
Cited by
Cited by
Inflammatory process in type 2 diabetes: The role of cytokines
K Alexandraki, C Piperi, C Kalofoutis, J Singh, A Alaveras, A Kalofoutis
Annals of the New York Academy of Sciences 1084 (1), 89-117, 2006
Indices of low-grade chronic inflammation in polycystic ovary syndrome and the beneficial effect of metformin
E Diamanti-Kandarakis, T Paterakis, K Alexandraki, C Piperi, A Aessopos, ...
Human Reproduction 21 (6), 1426-1431, 2006
Metformin administration improves endothelial function in women with polycystic ovary syndrome
E Diamanti-Kandarakis, K Alexandraki, A Protogerou, C Piperi, ...
European Journal of Endocrinology 152 (5), 749-756, 2005
Failure of mathematical indices to accurately assess insulin resistance in lean, overweight, or obese women with polycystic ovary syndrome
E Diamanti-Kandarakis, C Kouli, K Alexandraki, G Spina
The Journal of Clinical Endocrinology & Metabolism 89 (3), 1273-1276, 2004
Inflammatory and endothelial markers in women with polycystic ovary syndrome
E Diamanti‐Kandarakis, K Alexandraki, C Piperi, A Protogerou, I Katsikis, ...
European journal of clinical investigation 36 (10), 691-697, 2006
The ectopic ACTH syndrome
KI Alexandraki, AB Grossman
Reviews in endocrine and metabolic disorders 11 (2), 117-126, 2010
Long-term remission and recurrence rates in Cushing’s disease: predictive factors in a single-centre study
KI Alexandraki, GA Kaltsas, AM Isidori, HL Storr, F Afshar, I Sabin, ...
Eur J Endocrinol 168 (4), 639-648, 2013
Cytokine secretion in long-standing diabetes mellitus type 1 and 2: associations with low-grade systemic inflammation
KI Alexandraki, C Piperi, PD Ziakas, NV Apostolopoulos, K Makrilakis, ...
Journal of clinical immunology 28 (4), 314-321, 2008
Aggressive pituitary tumors
E Chatzellis, KI Alexandraki, II Androulakis, G Kaltsas
Neuroendocrinology 101 (2), 87-104, 2015
The prevalence of 4G5G polymorphism of plasminogen activator inhibitor-1 (PAI-1) gene in polycystic ovarian syndrome and its association with plasma PAI-1 levels
E Diamanti-Kandarakis, G Palioniko, K Alexandraki, A Bergiele, ...
European journal of endocrinology 150 (6), 793-798, 2004
Endocrine manifestations in Langerhans cell histiocytosis
P Makras, KI Alexandraki, GP Chrousos, AB Grossman, GA Kaltsas
Trends in Endocrinology & Metabolism 18 (6), 252-257, 2007
Patients with apparently nonfunctioning adrenal incidentalomas may be at increased cardiovascular risk due to excessive cortisol secretion
II Androulakis, GA Kaltsas, GE Kollias, AC Markou, AK Gouli, DA Thomas, ...
The Journal of Clinical Endocrinology & Metabolism 99 (8), 2754-2762, 2014
Comparisons in the epidemiology, diagnostic features and cure rate by transsphenoidal surgery between paediatric and adult-onset Cushing's disease
HL Storr, KI Alexandraki, L Martin, AM Isidori, GA Kaltsas, JP Monson, ...
European Journal of Endocrinology 164 (5), 667, 2011
The prevalence and characteristic features of cyclicity and variability in Cushing's disease
KI Alexandraki, GA Kaltsas, AM Isidori, SA Akker, WM Drake, SL Chew, ...
European journal of endocrinology 160 (6), 1011-1018, 2009
Long-acting somatostatin analogues are an effective treatment for type 1 gastric carcinoid tumours
S Grozinsky-Glasberg, G Kaltsas, C Gur, E Gal, D Thomas, S Fichman, ...
European journal of endocrinology 159 (4), 475, 2008
Evaluation of serum procalcitonin and interleukin-6 levels as markers of liver metastasis
V Matzaraki, KI Alexandraki, K Venetsanou, C Piperi, P Myrianthefs, ...
Clinical biochemistry 40 (5-6), 336-342, 2007
Effect of metformin administration on plasma advanced glycation end product levels in women with polycystic ovary syndrome
E Diamanti-Kandarakis, K Alexandraki, C Piperi, A Aessopos, T Paterakis, ...
Metabolism 56 (1), 129-134, 2007
Long-term follow-up of a large series of patients with type 1 gastric carcinoid tumors: data from a multicenter study
D Thomas, AV Tsolakis, S Grozinsky-Glasberg, M Fraenkel, K Alexandraki, ...
Eur J Endocrinol 168 (2), 185-193, 2013
The knowledge of osteoporosis risk factors in a Greek female population
KI Alexandraki, V Syriou, PD Ziakas, NV Apostolopoulos, AI Alexandrakis, ...
Maturitas 59 (1), 38-45, 2008
Hyperandrogenism after menopause
MC Markopoulos, E Kassi, KI Alexandraki, G Mastorakos, G Kaltsas
Eur J Endocrinol 172 (2), R79-R91, 2015
The system can't perform the operation now. Try again later.
Articles 1–20